poisar

Stocks · News reference

Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112

BenzingaAug 11, 2026, 5:38 PMBenzinga Newsdesk

Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $85 to $112.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 11, 2026, 5:38 PM
Checked
Aug 11, 2026, 5:38 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 21, 2026, 8:26 PMSEC EDGAR

    8-K filing — Hinge Health, Inc. (HNGE)

    Filed: 2026-08-21 AccNo: 0001628280-26-058439 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

    Read original at edgar